FDA Adverse Event Injury Summary report: N

CORAIL2 NON COL HO SIZE 11

MDR report key: 3362150 · Received September 23, 2013

Report

Report Number
1818910-2013-28140
Event Type
Injury
Date Received
September 23, 2013
Date of Event
July 16, 2012
Report Date
September 10, 2013
Manufacturer
DEPUY FRANCE SAS - 3003895575
Product Code
KWA
PMA / PMN Number
PK042992
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A SEARCH OF THE COMPLAINT DATABASE FOUND NO ADDITIONAL RELATED REPORTS FOR THE LOT CODES 2891286 AND 5006670. A SEARCH OF THE COMPLAINT DATABASE FINDS ADDITIONAL REPORTED INCIDENTS AGAINST LOT CODE 2732762 SINCE ITS RELEASE FOR DISTRIBUTION; HOWEVER, A PREVIOUS REVIEW OF THE DEVICE HISTORY RECORDS DID NOT REVEAL ANY RELATED MANUFACTURING ANOMALIES. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED.DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

LITIGATION ALLEGES PAIN, DISCOMFORT, METALLOSIS AND ELEVATED LEVELS OF COBALT AND CHROMIUM. UPDATE: (B)(6) 2013 - PFS WAS RECEIVED FROM LEGAL, MEDICAL RECORDS WERE RECEIVED FROM LEGAL, AND PART/LOT INFORMATION WAS IDENTIFIED. RECORDS INDICATE THAT THE PATIENT WAS REVISED BECAUSE OF PAIN AND LOOSE STEM. RECORDS ARE AVAILABLE FOR FURTHER REVIEW.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
480115 CORAIL2 NON COL HO SIZE 11 FEMORAL STEM KWA DEPUY FRANCE SAS - 3003895575 5006670

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention